ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 265 filers reported holding ROYALTY PHARMA PLC in Q4 2021. The put-call ratio across all filers is 0.25 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,612,446 | +53.8% | 209,576 | +75.7% | 0.02% | +56.2% |
| Q2 2023 | $3,648,003 | +15.3% | 119,294 | +36.9% | 0.02% | +6.7% |
| Q1 2023 | $3,162,928 | +16.8% | 87,133 | +27.2% | 0.02% | +7.1% |
| Q4 2022 | $2,708,068 | +13.2% | 68,524 | +15.0% | 0.01% | 0.0% |
| Q3 2022 | $2,393,000 | +15.6% | 59,561 | +21.0% | 0.01% | +16.7% |
| Q2 2022 | $2,070,000 | +7.8% | 49,242 | -0.1% | 0.01% | +33.3% |
| Q1 2022 | $1,920,000 | +35.8% | 49,278 | +38.8% | 0.01% | +28.6% |
| Q4 2021 | $1,414,000 | +31.7% | 35,491 | +21.3% | 0.01% | +16.7% |
| Q3 2021 | $1,074,000 | -11.2% | 29,270 | -0.5% | 0.01% | -14.3% |
| Q2 2021 | $1,210,000 | -5.7% | 29,413 | 0.0% | 0.01% | -12.5% |
| Q1 2021 | $1,283,000 | +5.6% | 29,413 | +21.2% | 0.01% | +14.3% |
| Q4 2020 | $1,215,000 | – | 24,271 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 2,680,644 | $106,824,000 | 67.12% |
| SIGULER GUFF ADVISERS, LLC | 6,761,970 | $269,465,000 | 56.37% |
| Vantage Consulting Group Inc | 4,601,152 | $183,355,000 | 49.30% |
| Indie Asset Partners, LLC | 805,982 | $32,118,000 | 23.31% |
| HARVARD MANAGEMENT CO INC | 3,464,990 | $138,080,000 | 12.96% |
| Brown University | 621,759 | $24,777,000 | 6.04% |
| Overbrook Management Corp | 729,125 | $29,056,000 | 5.86% |
| Bleichroeder LP | 824,033 | $32,838,000 | 5.13% |
| Geo Capital Gestora de Recursos Ltd | 200,692 | $7,998,000 | 3.81% |
| Lagoda Investment Management, L.P. | 140,435 | $5,596,000 | 2.65% |